MCD vs PFE: Which Is the Better Buy?

Side-by-side comparison of McDonald's Corporation and Pfizer Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-18.
McDonald's Corporation ยท Consumer Cyclical
$252.78
+40.7% upside to fair value
Med Conviction Grade A High Quality
VS
Pfizer Inc. ยท Healthcare
$27.64
+12.0% upside to fair value
Med Conviction Grade B
QuantHub Verdict
MCD has more upside to fair value (+40.7%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric MCD PFE
Current Price $252.78 $27.64
Fair Value Estimate $355.71 $30.94
Upside to Fair Value +40.7% +12.0%
Market Cap $179.6B $157.5B
Forward P/E โ€” โ€”
EV / EBITDA 15.5x 17.4x
Price / Sales 6.5x 2.5x
Price / FCF 23.1x 14.3x
Revenue Growth YoY +3.8% +2.6%
Gross Margin 57.4% 71.3%
Operating Margin 45.8% 25.1%
Return on Equity -561.2% 4.9%
Dividend Yield 2.94% 6.22%
FCF Yield 4.32% 6.97%
Analyst Consensus Buy Hold
Investment Thesis
MCD โ€” McDonald's Corporation
McDonald's operates a globally scaled, approximately 95% franchised restaurant system with 46,028 restaurants in more than 100 countries, combining a powerful consumer brand, real-estate-backed franchise economics, supplier scale and digital loyalty reach. Business quality is high despite meaningful leverage: TTM gross, operating and net margins are 57.4%, 45.8% and 31.7%, respectively, while loyโ€ฆ
PFE โ€” Pfizer Inc.
Pfizer is a global biopharmaceutical leader with a portfolio spanning cardiovascular, oncology, vaccines, immunology, and rare disease, anchored by Eliquis, the Prevnar family, Vyndaqel, Ibrance, Xtandi, Comirnaty, and Paxlovid, and supported by roughly 75,000 employees and a contract manufacturing division. Business quality is medium rather than high: TTM gross margin of 71.3% and TTM operating โ€ฆ
Accumulation Zones
Metric MCD PFE
Zone Low $266.78 $23.21
Zone High $302.35 $26.30
In Buy Zone? Yes No
โ† MCD Research    PFE Research โ†’    All Research